Accuracy of budget impact estimations and impact on patient access: a hepatitis C case study

por Geenen, Joost W., Boersma, Cornelis, Klungel, Olaf H., Hövels, Anke M.
Publicado 2019

Affordability of oncology drugs: accuracy of budget impact estimations

por Geenen, Joost W., Jut, Mark, Boersma, Cornelis, Klungel, Olaf H., Hövels, Anke M.
Publicado 2019

Increasing the information provided by probabilistic sensitivity analysis: The relative density plot

por Geenen, Joost W., Vreman, Rick A., Boersma, Cornelis, Klungel, Olaf H., Hövels, Anke M., Ham, Renske M. T. Ten
Publicado 2020

Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia

por Vreman, Rick A., Geenen, Joost W., Hövels, Anke M., Goettsch, Wim G., Leufkens, Hubert G. M., Al, Maiwenn J.
Publicado 2019

The Application and Implications of Novel Deterministic Sensitivity Analysis Methods

por Vreman, Rick A., Geenen, Joost W., Knies, Saskia, Mantel-Teeuwisse, Aukje K., Leufkens, Hubert G. M., Goettsch, Wim G.
Publicado 2020

A novel method for predicting the budget impact of innovative medicines: validation study for oncolytics

por Geenen, Joost W., Belitser, Svetlana V., Vreman, Rick A., van Bloois, Martijn, Klungel, Olaf H., Boersma, Cornelis, Hövels, Anke M.
Publicado 2020